NCT05756712

The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test

A Randomized, Double-blind, Cross-over Clinical Trial of the Efficacy of White Kidney Bean on Oral Glucose Tolerance Test

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 34 (actual)
• Sponsor: Shenzhen Precision Health Food Technology Co. Ltd., · Other Government
• Sex: All
• Age: 25 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The goal of this randomized, double-blind, cross-over inverventional study is to evaluate the efficacy of white kidney bean on OGTT (oral glucose tolerance test). About 34 eligible participants will be randomized in two groups of the same size to take the assigned interventions at one study site in Shanghai, two visits will be required. The first group of participants will take Wonderlab product first and then placebo product after 72 hours of washout period, while the other group of of participants will take placebo product first and then Wonderlab product after 72 hours of washout period. For each visit, the finger blood will be sampled and the relevent data such as blood glucose will be captured based on OGTT procedures, and recorded into clinical data management system for statistical analysis. Researchers will compare the two groups to see if there is significant change of blood glucose by using products containing ingredient of white kidney beans.

Conditions

• Diabetes
• Sugar; Blood, High

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Phase 1 Wonderlab Product	Chew two tablets of Wonderlab Product for phase 1 (day 1)
DIETARY_SUPPLEMENT	Phase 1 Placebo	Washout 72 hours and chew two tablets of placebo for phase 2 (day 4).
DIETARY_SUPPLEMENT	Phase 2 Placebo	Chew two tablets of placebo for phase 1 (day 1)
DIETARY_SUPPLEMENT	Phase 2 Wonderlab Product	Washout 72 hours and chew two tablets of Wonderlab Product for phase 2 (day 4).

Timeline

• Start date: 2023-03-06
• Primary completion: 2023-03-15
• Completion: 2023-03-31
• First posted: 2023-03-06
• Last updated: 2023-04-04

Locations

1 site across 1 country: China